# FDA Inspection 1227555 - Bloodworks - December 21, 2023

Source: https://www.keypedia.com/records/fda_inspections/bloodworks/956a02a3-5aab-439b-8e36-3dd10060e732
Source feed: FDA_Inspections

> FDA Inspection 1227555 for Bloodworks on December 21, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1227555
- Company Name: Bloodworks
- Inspection Date: 2023-12-21
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1077898 - 2019-01-25](https://www.keypedia.com/records/fda_inspections/bloodworks/7c852aaa-cc80-4854-b1c0-4707386ce794)
- [FDA Inspection 1007839 - 2017-04-17](https://www.keypedia.com/records/fda_inspections/bloodworks/bb6738e4-5a69-42db-aeea-265d591059d7)

Company: https://www.keypedia.com/companies/bloodworks/07e3a0a0-ce27-4a39-9197-6939ae701f83

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d